
Sitagliptin and risk of fractures in type 2 diabetes: Results from the TECOS trial
Author(s) -
R.G. Josse,
S.R. Majumdar,
Y. Zheng,
A. Adler,
M.A. Bethel,
J.B. Buse,
J.B. Green,
K.D. Kaufman,
H.W. Rodbard,
T. Tankova,
C.M. Westerhout,
E.D. Peterson,
R.R. Holman,
P.W. Armstrong,
TECOS Study Group
Publication year - 2017
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/ne8e-jp28
Subject(s) - sitagliptin , type 2 diabetes , medicine , diabetes mellitus , sitagliptin phosphate , endocrinology